PRNB Stock, Principia Biopharma Inc. Information
Stock Information
Get PRNB Alerts
News, Short Squeeze, Breakout and More Instantly...
About Principia Biopharma Inc.
Principia Biopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing novel therapies for immunology and oncology. Its proprietary Tailored Covalency platform enables to design and develop reversible and irreversible covalent small molecule inhibitors with potencies and selectivities. The company pipeline products include PRN1008 and PRN2246 and PRN1371 under BTK franchise.